Eddie Cliff: COALITION Study Compares Results of Glofitamab Combinations in LBCL
Eddie Cliff, Haematology Registrar at Peter MacCallum Cancer Centre, shared a post on X about a paper by Michael J. Dickinson et al. published in the Journal of Clinical Oncology:
“Just out at Journal of Clinical Oncology:
COALITION study comparing glofitamab plus PolaR-CHP vs glofit-R-CHOP in frontline large B cell lymphoma – very exciting:
n=80
ORR 100%
CRR 98%
21-month PFS 86%, OS 92%.”
Title: Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study
Authors: Adrian Minson, Emma Verner, Pratyush Giri, Jason Butler, Wojt Janowski, Chan Y. Cheah, Sumita Ratnasingam, Shu Min Wong, Matthew Ku, Mark Hertzberg, Kirsten Herbert, Nada Hamad, Costas K. Yannakou, Fiona Swain, Paul Neeson, Thiago M. Steiner, Javad Saghebi, Piers Blombery, Sally M. Hunter, Molly Robertson, Lei Shong Lau, Rory Bennett, Sean Harrop, Jing Xie, John F. Seymour, Michael J. Dickinson
You can read the Full Article in the Journal of Clinical Oncology.
More posts featuring Eddie Cliff.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023